The double role of Kras in lung carcinogenesis—tumor suppressor when wild-type and oncogene when mutated—led to the hypothesis that lung cancer susceptibility could result from the subtle balance between expression levels of wild-type and mutated Kras[13]. This evidence concerns the gene KRAS and lung carcinoma.